Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hepatitis
Symptom |infection
Sentences 1297
PubMedID- 21092242 The patients were divided into three groups: (i) control (non-malignant disease), either chronic hepatitis patients with hbv/hcv infection (n = 49) or cirrhotic patients (n = 47); (ii) afp-low hcc (n = 61); and (iii) afp-high hcc (n = 63).
PubMedID- 23291588 Chronic infection with hepatitis c virus (hcv) is a common cause of liver cirrhosis and cancer.
PubMedID- 25182146 Cirrhosis due to metabolic syndrome, alcohol consumption, viral infection with hepatitis c virus (hcv) is also involved in its development.
PubMedID- 26288635 infection with hepatitis c virus (hcv) is a grave public health problem and medical issue in the world.
PubMedID- 23007692 The eligibility criteria were: (1) >18 years of age; (2) prior triple-drug antiretroviral regimen; (3) durability of current treatment >18 months; (4) viral load <400 copies/ml over the 18 months before evaluation and <50 copies/ml over the last 6 months; (5) cd4 count >/=250 cells/mul; (6) cd4 count nadir >100 cells/mul; (7) no previous virological failure under prior protease inhibitor-based regimen; (8) absence of co-infection with hepatitis b virus; (9) absence of hiv-related neurological disease; and (10) adherence >95 %.
PubMedID- 26159282 Background: opportunities to treat infection with hepatitis c virus (hcv) are evolving rapidly.
PubMedID- 26048049 Determinants of polyneuropathy were urban residence (p=0.02), infection with hepatitis c virus (p=0.002), infection with hiv (p=0.012) and presence of albuminuria (p=0.0001).
PubMedID- 26295392 Hepatocellular carcinoma (hcc) is a common, life-threatening complication of longstanding infection with the hepatitis c virus (hcv), likely a consequence of the direct oncogenic activity of the virus cooperating with liver cell inflammation in transforming the liver into a mitogenic and mutagenic environment.
PubMedID- 23498824 Background: chronic infection with hepatitis e virus (hev) has recently been recognized in immunocompromised or immunosuppressed individuals.
PubMedID- 26062906 infection with hepatitis b virus (hbv) remains a worldwide health problem, and dna-based vaccines against hbv have been tested for therapeutic applications.
PubMedID- 22308125 In spite of the availability of a highly effective vaccine, approximately one third of the world's population has serological findings of past or present infection with hepatitis b virus (hbv); and globally, over 350 million people are currently chronically infected.
PubMedID- 23315914 Chronic infection with the hepatitis c virus (hcv) is a leading cause of global morbidity and mortality.
PubMedID- 24765267 As enteric fever is a common infection, the recognition of salmonella hepatitis is of clinical importance.
PubMedID- 22506050 Chronic infection with hepatitis b virus (hbv) has been recognized as a major cause of hcc .
PubMedID- 23869873 Background and aim: chronic infection with hepatitis c virus (hcv) decreases health-related quality of life (hrqol).
PubMedID- 22308122 In a study conducted on addict prisoners in khazarabad, iran in 2001, tattooed inmates were shown to have at least 3.5 times higher risk of infection with hepatitis c. moreover, 30.8% of the cases were found to have hepatitis c, 81.7% of which were idus .indeed, tattooing may be a major route of hcv transmission.
PubMedID- 25875501 Hcv infection may lead to chronic hepatitis, liver cirrhosis and hcc, which cause a serious burden on global public health and hence prompt many efforts to elucidate hcv replication and pathogenesis .
PubMedID- 26286149 Exclusion criteria were: 1) overt infection with other hepatitis viruses (i.e.
PubMedID- 23031791 Hcv infection often leads to chronic hepatitis, cirrhosis, and occasionally to hepatocellular carcinoma.
PubMedID- 22398573 Super-infection with genotype 4 hepatitis c virus in a patient treated for genotype 3 acute hepatitis c.
PubMedID- 21326840 Chronic infection with hepatitis c virus is estimated to affect almost 4 million people in the usa, 5 million in europe, and 170 million worldwide 1.
PubMedID- 21452121 Reactivation, recurrence or acute infection with hepatitis b virus (hbv) represent severe complications of biological therapy.
PubMedID- 22448150 Other covariates were age (in the year 2000), gender, intravenous drug use as the likely mode of hiv transmission, viral load, co-infection with hepatitis b or c, cart category, and the number of prior cart regimens, with these last three covariates updated for each interval.
PubMedID- 22158321 In addition to these associations, there is substantial evidence for a causativerelationship between chronic infection with hepatitis c virus (hcv) and non-hodgkinlymphoma (nhl), an association that has been the subject of several recentsystematic reviews (gisbert et al, 2003;matsuo et al, 2004; dal maso and franceschi, 2006).
PubMedID- 26042425 infection with the hepatitis c virus (hcv) is an important emerging public health issue for both developed and developing nations; an estimated 185 million people world-wide have been infected with hcv 1.
PubMedID- 22208719 infection with hepatitis b virus (hbv), which can cause acute and chronic liver diseases, remains one of the most serious viral infections in humans.
PubMedID- 23585765 Since tfh can produce and secrete il-21 (10, 11), which can increase proliferation of virus specific ctl (12, 14), there may be a certain relationship between tfh and infection with hepatitis b virus.
PubMedID- 21617315 Characterization of splenic cells during the early phase of infection with neuropathogenic mouse hepatitis virus.
PubMedID- 20470823 Co-infection with hepatitis b, c and b + c were present in 6.7%, 5.7% and 1.7% respectively.
PubMedID- 26378794 It is possible that some participants in some studies were not excluded, due to co-infection with hepatitis c virus, as observed in the study of perez et al .
PubMedID- 23248376 A case of fulminant varicella infection with purpura fulminans, hepatitis, and rhabdomyolysis.
PubMedID- 24829683 Health workers could be at a higher risk of infection with hepatitis a virus (hav) compared to the general population.
PubMedID- 24523215 Background: infection with hepatitis c virus (hcv) increases the risk of death from liver and nonliver-related diseases.
PubMedID- 25786459 Recently, chronic infection with hepatitis e virus (hev) genotype 3 has been reported in immunocompromised patients.
PubMedID- 22745767 Our interest for these diseases depends from the fact that southern italy shows the highest rates of type2 diabetes/obesity and, also, of liver cancer for europe, mainly related to infection with hepatitis viruses (i.e.
PubMedID- 25729482 infection with hepatitis b virus (hbv) poses a major health threat worldwide, where the magnitude and overburden of chronic carrier state approaches 150 million chronic carriers.
PubMedID- 23185336 Key exclusion criteria were the followings: the time point of acute onset of achblf was more than 14 days prior to the enrollment date; clinical evidence of cirrhosis or documented stage iv fibrosis on liver biopsy (if available); co-infection with hepatitis a, c, d, e or hiv virus; pregnant woman; diagnosis of other liver diseases including autoimmune hepatitis and wilson disease, or evidence of hepatic tumor; history of renal, cardiovascular, pulmonary, endocrine or neurological diseases; history of antiviral therapy prior to the onset of achblf, history of drug abuse including alcohol abuse; treatment with immune modulator, antibiotic treatment, or chinese herbal medicine within six months prior to the screening.
PubMedID- 22308136 infection with hepatitis b virus (hbv) and hepatitis c virus (hcv) is a problem of worldwide significance 1.
PubMedID- 25390287 The hepatic consequences of an infection with the hepatitis c virus (hcv) are well recognised, but extrahepatic manifestations of hcv may be just as severe.
PubMedID- 21174240 The comorbid conditions specifically addressed in the guidelines include developmental disabilities, alcohol and other substance use disorders, traumatic brain injuries and other non-hiv-related neurologic conditions, systemic diseases including co-infection with hepatitis c virus, and hiv-related opportunistic cns disease.
PubMedID- 21935331 We therefore performed an economic analysis to estimate the cost-effectiveness of the treatments licensed in italy for managing hbv infection in patients with chronic hepatitis and cirrhosis.
PubMedID- 26075599 Chronic infection with hepatitis c virus (hcv) is known as the major agent of chronic liver disease, hepatic cirrhosis, and hepatocellular carcinoma.
PubMedID- 22347865 Acute hav super infection in carriers of chronic hepatitis c has been associated with a particularly high mortality rate, dozens of times higher than hav infection in the gpop (who, 2000; keeffe, 2006; kumar and herrera, 2010).
PubMedID- 23634229 The etiological importance of chronic infection with the hepatitis b virus (hbv) and the hepatitis c virus (hcv) in hcc has been well established 3.
PubMedID- 26113910 Incidence of hepatocellular carcinoma in chronic infection with hepatitis b.
PubMedID- 21618261 Background: chronic infection with hepatitis b virus and hepatitis delta virus (hdv) results in the most severe form of viral hepatitis.
PubMedID- 24077625 It still remains unclear how occult hbv infection affects the treatment of chronic hepatitis c.
PubMedID- 20924215 Exclusion criteria included co-infection with hepatitis c, or the human immunodeficiency virus; evidence of cirrhosis or hepatocellular carcinoma; previous exposure to any nucleoside analog that is active against hbv; use of interferon alpha within 6 months before enrollment.
PubMedID- 24564861 The major etiology of hepatocellular carcinoma is infection with hepatitis b virus (hbv) and/or hepatitis c virus (hcv) , which can lead to liver cirrhosis, the main risk factor for hcc.
PubMedID- 20156300 Persistent infection with hepatitis c virus (hcv) is a major risk toward development of hepatocellular carcinoma (hcc).

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26